ubenimex has been researched along with Lymphoma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arimori, S; Komatsuda, M; Nagao, T; Shimizu, Y; Watanabe, K | 1 |
| Erbeznik, H; Hersh, LB | 1 |
| Abe, F; Black, PL; Schneider, M; Talmadge, JE | 1 |
| Bruley-Rosset, M; Payelle, B; Rappaport, H | 1 |
| Tsukagoshi, S | 1 |
5 other study(ies) available for ubenimex and Lymphoma
| Article | Year |
|---|---|
The effect of bestatin on patients with acute and chronic leukemia and malignant lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Female; Humans; Leucine; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged | 1980 |
A novel mammalian high-molecular-weight aminopeptidase.
Topics: Alanine; Amides; Aminopeptidases; Arginine; Brain; Chromatography, Gel; Enzyme Inhibitors; Humans; Immune Sera; Isoenzymes; Kinetics; Leucine; Lymphoma; Molecular Weight; Peptides; Puromycin; Spleen; Substrate Specificity; Tumor Cells, Cultured | 1997 |
Chemoimmunotherapy with cyclophosphamide and bestatin in experimental metastasis in mice.
Topics: Adjuvants, Immunologic; Animals; Combined Modality Therapy; Cyclophosphamide; Cytotoxicity, Immunologic; Immunity, Cellular; Killer Cells, Natural; Leucine; Lymphoma; Macrophages; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms, Experimental | 1989 |
Acceleration of age-associated immune decline and mortality by early repeated administration of bestatin to C57BL/6 mice.
Topics: Adjuvants, Immunologic; Aging; Animals; Cytotoxicity Tests, Immunologic; Female; Hypersensitivity, Delayed; Immunologic Deficiency Syndromes; Injections, Intraperitoneal; Interleukin-1; Interleukin-2; Killer Cells, Natural; Leucine; Life Expectancy; Lymphoma; Macrophages; Mice; Mice, Inbred C57BL; Rodent Diseases; T-Lymphocytes | 1986 |
[A new antitumor drug with immunomodulating activity, ubenimex (bestatin)].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Animals; Female; Humans; Leucine; Leukemia; Leukemia P388; Leukemia, Myeloid; Lymphoma; Male; Mice; Middle Aged; T-Lymphocytes | 1987 |